Shares of Craneware Plc (CRW.L) are up 5 percent on Wednesday's trading after the company said that it expects fiscal 2025 adjusted EBITDA to rise 12 percent to over $65 million, compared to last year's $58.3 million. The company, which offers revenue integrity solutions to healthcare providers, added that revenue is expected to rise 9 percent to $205.7 million from $189.3 million reported in fiscal 2024.
On the LSE, the stock is up 5 percent on Wednesday's trading at 2,355.00 pence.
Craneware said that Annual Recurring Revenue or ARR increased 7 percent to around $184 million, while the Net Revenue Retention or NRR improved to 107 percent from last year's 98 percent.
The company expects the ongoing push for greater efficiency and value within the US healthcare sector to continue creating a favorable environment for its solutions.
The strategic partnership with Microsoft is progressing well, significantly enhancing its visibility and that of its AI-powered Trisus platform among hospital CIOs across America, Craneware added.
Looking ahead, the company said that with higher EBITDA, ARR, and NRR, its Board is confident of reaching a higher revenue growth rate in fiscal 2026.
Craneware will announce its fiscal 2025 results on September 15.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.